By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.




CEO: Pascal Soriot

CFO: Marc Dunoyer

CMO: Marc Dunoyer

CTO: Andrew Chen

CCO: Katarina Ageborg

CMO: Sean Bohen


Please click here for clinical trial information.


Please click here for AstraZeneca job opportunities.


AstraZeneca Medications

For more information, visit and follow us on


Key Statistics

Ownership: Public

Web Site: AstraZeneca PLC
Employees: 50,000 worldwide
Symbol: AZN

Company News
Eli Lilly (LLY), AbbVie (ABBV) Top 2017 Rankings; Pfizer (PFE), AstraZeneca PLC (AZN) Flailing 10/19/2016 7:48:49 AM
3SBio (SSRX) Pays $100 Million To Market Two AstraZeneca PLC (AZN) Diabetes Drugs In China 10/12/2016 10:42:22 AM
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial 10/12/2016 5:41:58 AM
AstraZeneca PLC (AZN) Release: Durvalumab Shows Promising Preliminary Early Data In Lung And Head & Neck Cancers 10/10/2016 11:49:53 AM
Tesaro (TSRO) Jumped on PARP Ovarian Cancer Win Vs. AstraZeneca PLC (AZN), AbbVie (ABBV) 10/10/2016 9:17:03 AM
Deal Spree Continues as AstraZeneca PLC (AZN) Inks $330 Million Pact With Johnson & Johnson (JNJ) 10/7/2016 5:37:09 AM
AstraZeneca PLC (AZN) Terminated 50 Sales Staff in India Last Week 10/6/2016 6:16:52 AM
AstraZeneca PLC (AZN) Release: New Study Shows Increases In RSV Hospitalization Among High-Risk Preterm Infants 10/5/2016 10:59:22 AM
On a Roll, AstraZeneca PLC (AZN) Licenses Respiratory Drug to Insmed (INSM) in $150 Million Deal 10/5/2016 6:05:18 AM
AstraZeneca PLC (AZN) Furthers Sell-Off Strategy With New $175 Million Deal 10/4/2016 5:49:36 AM